Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells. - Vidana Gamage HE; Albright ST; Smith AJ; Farmer R; Shahoei SH; Wang Y; Fink EC; Jacquin E; Weisser E; Bautista RO; Henn MA; Schane CP; et al. (Cancer letters, 2024)